Navigation Links
BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
Date:8/19/2007

in

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio is comprised of two approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin, and Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation. Investigational product candidates include Kuvan(TM) (sapropterin dihydrochloride), a Phase 3 product candidate for the treatment of phenylketonuria (PKU), and 6R-BH4 for cardiovascular indications, which is currently in Phase 2 clinical development for the treatment of peripheral arterial disease and sickle cell disease. Both products are being developed in partnership with Merck Serono, a division of Merck KgA of Darmstadt, Germany. For additional information, please visit http://www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

About AnGes MG, Inc.

AnGes MG, Inc., a biopharmaceutical company founded in 1999, was established on an innovative discovery by researchers of Osaka University. The company specializes in research, development and practical application of genetic medicine. Current programs include the Hepatocyte Growth Factor (HGF) genetic medicine which improves blood circulation by regenerating blood vessels, and an NFkB decoy that controls various types of inflammation.

Forward-Looking Statement

This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the potential approval of Naglazyme in Japan; the continued clinical development and commercialization of Naglazyme; actions
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
2. GenoLogics Announces Bioinformatics Partnership with Illumina
3. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
4. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
5. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
6. Inovio Biomedicals Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials
7. Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Companys Investigational Drug to Treat Cocaine and Methamphetamine Addiction
8. Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
9. KineMed Presents Data Measuring Changes in Reverse Cholesterol Transport for the First Time
10. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
11. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015 ... announced the addition of the "North American ... Graft), by Application (Surgical Wound, & Ulcer), by ... to 2019" report to their offering. ,     ... care market is estimated to grow at a ...
(Date:5/21/2015)... 2015  Cardica, Inc. (Nasdaq: CRDC ) today announced ... , the company,s vice president of operations, was granted an ... at a per share exercise price of $0.43, the closing ... granted pursuant to Cardica, Inc.,s Inducement Plan, which was approved ... Rule 5653(c)(4) of the Nasdaq Global Market for equity grants ...
(Date:5/21/2015)... , May 21, 2015 ... Arzneimittelfälschungen - Zwecks Leistungsvergleich zur Expertise ... auf EG-Mitgliedstaaten verwiesen, in denen uneingeschränkt ... Wählen Sie ein Aegate-Land: beispielsweise BELGIEN ... zur Bekämpfung von Arzneimittelfälschungen (FMD) handelt ...
Breaking Medicine Technology:North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Cardica Announces New Employment Inducement Grant 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3
(Date:5/25/2015)... After the sensational buzz surrounding their past two ... Trivedi Master Wellness™ agrees to hold another ... “Consciousness is Power.” Presently, the Live-Streaming event is scheduled ... routinely allotted time from 10:00pm PST/1:00pm EST to 6:00pm ... to the public and accessible on the web through ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 Decora Preset ... ‘Leviton’ is now available on ‘The Hardware City.’ The product ... has to set a time and the related electronic device ... contacted a representative of the company said, “We are glad ... City.’ Now customers can buy Countdown Timer Switch in just ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 Women's ... about hair loss. Although it is unclear about the ... are environmental factors such as metabolism, nutritional deficiencies, thyroid ... they offer a comprehensive approach to evaluating the metabolic, ... woman, they can help patients find a cause for ...
(Date:5/24/2015)... 24, 2015 Scientists with Cardno ChemRisk, ... air quality compliance issues that may have raised the ... Mesothelioma has just posted an article on the research. ... The group found airborne asbestos levels well above OSHA ... 1984 and 2011. , “Asbestos compliance sampling data associated ...
(Date:5/24/2015)... Viejo, CA (PRWEB) May 24, 2015 ProPin ... use in Final Cut Pro X. Utilize ProPin to pin ... in a given scene. , ProPin allows users to ... completely customizable in FCPX. With on-screen controls, video editors can ... allows users to pin and mark with absolute ease. , Using ...
Breaking Medicine News(10 mins):Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 2Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 3Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2
... hospitals and the,Coalition to Protect Florida,s Drivers lauded ... restore no-fault auto insurance, calling it a,"great protection" ... Governor Crist,s signing into law of CS/HB ... Personal Injury Protection (PIP),coverage, will be restored on ...
... levels of protein indicating damage returned to normal ... News) -- Preliminary research suggests that potent AIDS drugs ... infected with HIV. , The findings are based upon ... so it,s not clear exactly what they mean for ...
... Inc.,(NYSE: CAH ), a global provider of products and ... to release first-quarter,results for its fiscal 2008 on Monday, Nov. ... Stock Exchange. The company has scheduled a conference call ... To access the call and corresponding slide,presentation, go to the ...
... Transfer to Healthcare Marketplace -, ATLANTA, Oct. ... community management (BCM) solutions, today announced it,is sponsoring ... Electronic Data Interchange (WEDI) Conference on Health Savings,Accounts ... BizManager,suite and Secure Link solution. The conference is ...
... Once-In-A-Lifetime Opportunity, BOCA RATON, Fla., Oct. 11 ... with American Exhibitions, Inc., is pleased to,announce the ... to its existing,Orlando, Detroit and Rochester installations. ... THE UNIVERSE WITHIN will open at the Science ...
... point to serious shortcomings, some experts say , , THURSDAY, Oct. ... Topps, which billed itself as the leading U.S. maker of ... million pounds of beef due to E. coli ... pounds of a brand of beef patties believed to be ...
Cached Medicine News:Health News:Hospital Coalition Says Governor's No-Fault Bill Signing Provides a 'Great Protection' for Florida Consumers 2Health News:AIDS Drugs May Protect Brain 2Health News:Cardinal Health To Announce First-Quarter Results on November 5 2Health News:Inovis Sponsors ASC X12 Conference, Exhibits BizManager and Secure Link 2Health News:Our Body: The Universe Within Exhibition Announces Four New Exhibits Across The Nation 2Health News:Concerns Rise Over U.S. Food Safety 2Health News:Concerns Rise Over U.S. Food Safety 3Health News:Concerns Rise Over U.S. Food Safety 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: